DRI-C21095

N/A

Report date: 2025/02/18 17:35:04
NME

Base Information

Drug NameDRI-C21095
Drug Alias NameDRI-C21095
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Miami Miller School of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Miami Miller School of Medicine
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A